NIH-funded research NIH-funded research

Acquisition of a Spinning Disk Confocal Microscope at Winthrop University

Official title: The Acquisition of a Spinning Disk Confocal Microscope

Funded at Winthrop University · NIH-11364212 · Data updated 2026-11-12

A new spinning disk confocal microscope will empower Winthrop University researchers and students to capture high-resolution 3D images for biology and tissue studies.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionWinthrop University
NIH-funded
Lab location1 site (Rock Hill, United States)
Project startAugust 5, 2026
Project endAugust 4, 2027
Funding year2026
Award (this year)$249,702
NIH project number1S10GM164748-01
Project IDNIH-11364212 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are individuals whose conditions involve tissue analysis, corneal biology, or DNA repair research where advanced imaging could inform future diagnostics or therapies, typically within the university research ecosystem.

Less likely to help

Patients may not directly benefit from this grant, as it funds equipment for institutional research and education rather than a clinical intervention.

What this research studies

Winthrop University seeks to purchase a spinning disk confocal microscope to replace an aging system and reduce reliance on external imaging resources. The instrument will enable high-resolution 3D immunofluorescence imaging with an easy-to-use interface for both seasoned scientists and students. This grant supports acquisition, installation, and integration into teaching labs and ongoing research projects across multiple departments. It will enhance training in microscopy and potentially strengthen outreach and recruitment by expanding access to advanced imaging capabilities.

Why it matters

Potential benefit: Patients could benefit indirectly through faster, more accurate biomedical research that may lead to new insights into tissue biology and disease mechanisms.

How similar studies have gone: Prior work using improved imaging systems has enabled high-quality 3D tissue imaging, though the specific grant focuses on equipment purchase rather than a specific disease study.

Where this research is happening

  • Winthrop University
    Rock Hill, United States
    Active

Researchers

  • Principal investigator: Chojnowski, Jena L — Winthrop University
  • Study coordinator: Chojnowski, Jena L

Related research

Other NIH-funded projects on the same topics.

  • Understanding how a gene regulator may help fight glioblastoma

    Scientists are studying how a protein called RYBP affects glioblastoma cells to see if boosting this protein could slow down tumor growth.

    NIH research Winthrop University · Rock Hill, United States · NIH-11398012

  • How the RYBP protein affects glioblastoma tumor cells

    Researchers will test whether restoring the RYBP protein can reduce aggressive behaviors of glioblastoma cells.

    NIH research Winthrop University · Rock Hill, United States · NIH-11194243

  • Understanding how a specific protein affects glioblastoma cells

    This study is looking at a protein called RYBP to see how it helps fight glioblastoma, a tough type of brain cancer, and why it’s often less active in patients; by understanding this, researchers hope to find new ways to treat the disease.

    NIH research Winthrop University · Rock Hill, United States · NIH-10936126

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.